within Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopicalUse.R01AC08_Olopatadine;

model Olopatadine
  extends Pharmacolibrary.Drugs.ATC.R.R01AC08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R01AC08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Olopatadine is a selective histamine H1 receptor antagonist used as an antihistamine to treat allergic rhinitis and allergic conjunctivitis. It is available in oral, nasal, and ophthalmic formulations and is currently approved for use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Gonzalez-Estrada, A, et al., &amp; Eidelman, F (2017). Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. <i>Expert opinion on pharmacotherapy</i> 18(11) 1137–1143. DOI:<a href=&quot;https://doi.org/10.1080/14656566.2017.1346085&quot;>10.1080/14656566.2017.1346085</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28656804/&quot;>https://pubmed.ncbi.nlm.nih.gov/28656804</a></p></li><li><p>Nickels, AS, et al., &amp; Wolf, R (2011). Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis. <i>Expert opinion on drug metabolism &amp; toxicology</i> 7(12) 1593–1599. DOI:<a href=&quot;https://doi.org/10.1517/17425255.2011.630389&quot;>10.1517/17425255.2011.630389</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22032416/&quot;>https://pubmed.ncbi.nlm.nih.gov/22032416</a></p></li><li><p>Chu, NN, et al., &amp; Li, XN (2009). Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study. <i>Clinical drug investigation</i> 29(7) 451–457. DOI:<a href=&quot;https://doi.org/10.2165/00044011-200929070-00003&quot;>10.2165/00044011-200929070-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19499962/&quot;>https://pubmed.ncbi.nlm.nih.gov/19499962</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Olopatadine;
